Concepedia

Nicolas Marincek

NM

Statistics

Publications

11

Citations

1.2K

H-Index

11

Active since

2011

Affiliations

University Hospital of Bern(Current)

University Hospital of Basel

University of California, Los Angeles

McMaster University

University of Bern

Nicolas Marincek is an author at University Hospital of Bern specializing in medicine, oncology, and endocrine oncology.

Publications per year

2011–2016

11

Publications

11

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [<sup>90</sup>Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

Anna Imhof, Philippe Brunner, Nicolas Marincek et al. · Journal of Clinical Oncology · 2011 · 621 citations

Medicine, Oncology, Pharmacology +17

Cohort Study of Somatostatin-Based Radiopeptide Therapy With [<sup>90</sup>Y-DOTA]-TOC Versus [<sup>90</sup>Y-DOTA]-TOC Plus [<sup>177</sup>Lu-DOTA]-TOC in Neuroendocrine Cancers

Linda Villard, Anna Romer, Nicolas Marincek et al. · Journal of Clinical Oncology · 2012 · 184 citations · Full text

Medicine, Oncology, Pharmacology +16

Somatostatin Receptor–Targeted Radiopeptide Therapy with <sup>90</sup>Y-DOTATOC and <sup>177</sup>Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial

Nicolas Marincek, Piotr Radojewski, Rebecca A. Dumont et al. · Journal of Nuclear Medicine · 2015 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

Anna Romer, Daniela Seiler, Nicolas Marincek et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 76 citations · Full text

Medicine, Nuclear Medicine, Oncology +14

Upregulation of Key Molecules for Targeted Imaging and Therapy

Vincent Taelman, Piotr Radojewski, Nicolas Marincek et al. · Journal of Nuclear Medicine · 2016 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 11